Bookmark and Share

Hot Stock; Advaxis Inc. (ADXS)

Advaxis Inc. (OTC: ADXS), a clinical-stage biotechnology company engaged in the development of next generation of immunotherapies for cancer and infectious diseases, has seen a sharp rise in its shares in trading today.

ADXS shares are currently trading 15.56% higher at $0.104 on above average volume of 3.62 million.

Advaxis shares are gaining momentum after the company said that its ADXS-PSA construct caused substantial tumor regression in preclinical prostate cancer study. ADXS-PSA is Advaxis’s immunotherapy designed to target the PSA antigen associated with prostate cancer.

The preclinical research was conducted in collaboration with Dr. Chandan Guha and his laboratory at Montefiore Medical Center in Bronx, New York. The main goal of the study was to identify if the combination of ADXS-PSA immunotherapy and radiation therapy could improve upon the efficacy of either immunotherapy alone or radiation therapy alone in the treatment of mice bearing PSA-expressing TPSA23 tumors.


Leave a Reply




You can use these HTML tags

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

All stories in are for informational purposes only. This is NOT a stock recommendation. This story is a daily light analysis featuring a stock with insider buying. With some caveats, insiders purchase a stock because they think the stock is going up. There are other factors to consider such as size of the transaction relative to their compensation and net worth. Sometimes, insiders might be propping a stock price up for future financing. Sometimes, the amount of insider buying are misread or misreported. Each month, DailyStocks releases a a summary of the stocks with insider buying. Sign up for the free monthly newsletter at . About is the place where you can find stories about stocks with insider buying, where you can educate yourself about stock market investing, and where you can perform the stock search engine analysis – you enter a stock symbol, and you get a resulting page of stock ticker indexed links so that you do not have to type the stock symbol each time.